Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 2
2018 1
2019 1
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Polycystic liver disease 2"
Page 1
Outcomes associated with fetal hepatobiliary cysts: systematic review and meta-analysis.
Leombroni M, Buca D, Celentano C, Liberati M, Bascietto F, Gustapane S, Marrone L, Manzoli L, Rizzo G, D'Antonio F. Leombroni M, et al. Ultrasound Obstet Gynecol. 2017 Aug;50(2):167-174. doi: 10.1002/uog.17244. Epub 2017 Jul 9. Ultrasound Obstet Gynecol. 2017. PMID: 27553859 Free article. Review.
For fetal biliary cysts, resolution or reduction in cyst size occurred in 8.7% (95% CI, 2.7-17.5%) of cases and an increase in size occurred in 34.4% (95% CI, 20.5-49.8%). Congenital anomalies of the biliary tract and liver, such as fibrosis, occurred in 21.5% (95% CI, 10. …
For fetal biliary cysts, resolution or reduction in cyst size occurred in 8.7% (95% CI, 2.7-17.5%) of cases and an increase in size o …
Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review.
Natale P, Hannan E, Sautenet B, Ju A, Perrone RD, Burnette E, Casteleijn N, Chapman A, Eastty S, Gansevoort R, Hogan M, Horie S, Knebelmann B, Lee R, Mustafa RA, Sandford R, Baumgart A, Tong A, Strippoli GFM, Craig JC, Rangan GK, Cho Y. Natale P, et al. PLoS One. 2021 May 27;16(5):e0252479. doi: 10.1371/journal.pone.0252479. eCollection 2021. PLoS One. 2021. PMID: 34043715 Free PMC article.
We assessed the general characteristics and psychometric properties of all measures. 118 studies, we identified 26 measures: 12 (46%) measures were developed for a non-ADPKD population, 1 (4%) for chronic kidney disease, 2 (8%) for polycystic liver disease …
We assessed the general characteristics and psychometric properties of all measures. 118 studies, we identified 26 measures: 12 (46%) measur …
Somatostatin analog therapy effectiveness on the progression of polycystic kidney and liver disease: A systematic review and meta-analysis of randomized clinical trials.
Suwabe T, Barrera FJ, Rodriguez-Gutierrez R, Ubara Y, Hogan MC. Suwabe T, et al. PLoS One. 2021 Sep 24;16(9):e0257606. doi: 10.1371/journal.pone.0257606. eCollection 2021. PLoS One. 2021. PMID: 34559824 Free PMC article.
METHODS: Eligible studies included randomized controlled trials (RCTs) evaluating somatostatin analog as therapy for patients with polycystic kidney disease (PKD) or polycystic liver disease (PLD) compared to placebo or standard therapy. ...However, it was no …
METHODS: Eligible studies included randomized controlled trials (RCTs) evaluating somatostatin analog as therapy for patients with polycysti …
Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis.
Griffiths J, Mills MT, Ong AC. Griffiths J, et al. BMJ Open. 2020 Jan 9;10(1):e032620. doi: 10.1136/bmjopen-2019-032620. BMJ Open. 2020. PMID: 31924636 Free PMC article.
OBJECTIVES: A number of randomised control trials (RCTs) investigating the effects of long-acting somatostatin analogues in autosomal dominant polycystic kidney disease (ADPKD) and polycystic liver disease (PLD) have been recently reported. We sought to evalu …
OBJECTIVES: A number of randomised control trials (RCTs) investigating the effects of long-acting somatostatin analogues in autosomal domina …
Systematic review of laparoscopic versus open surgery in the treatment of non-parasitic liver cysts.
Antonacci N, Ricci C, Taffurelli G, Casadei R, Minni F. Antonacci N, et al. Updates Surg. 2014 Dec;66(4):231-8. doi: 10.1007/s13304-014-0270-3. Epub 2014 Oct 19. Updates Surg. 2014. PMID: 25326850 Review.
The overall complication rate was 33.3 % with a substantial equivalence between the two approaches (27.2 % for laparoscopic surgery and 36.6 % for laparotomic). The overall recurrence rate was 18.1 % with 36.3 % in the laparoscopic group and 9.2 % in the laparotomic …
The overall complication rate was 33.3 % with a substantial equivalence between the two approaches (27.2 % for laparoscopic surgery a …
Clinical response after laparoscopic fenestration of symptomatic hepatic cysts: a systematic review and meta-analysis.
Bernts LHP, Echternach SG, Kievit W, Rosman C, Drenth JPH. Bernts LHP, et al. Surg Endosc. 2019 Mar;33(3):691-704. doi: 10.1007/s00464-018-6490-8. Epub 2018 Oct 17. Surg Endosc. 2019. PMID: 30334152 Free PMC article.
BACKGROUND: Laparoscopic fenestration is one of the treatment options for symptomatic hepatic cysts, either solitary or in context of polycystic liver disease (PLD), but indications, efficacy and surgical techniques are under debate. ...Post-operative complic …
BACKGROUND: Laparoscopic fenestration is one of the treatment options for symptomatic hepatic cysts, either solitary or in context of pol …